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Introduction {#embr201845986-sec-0001}
============

Prostate cancer (PC) is the most common male malignancy in the United States [1](#embr201845986-bib-0001){ref-type="ref"} and the sixth leading cause of cancer deaths in men worldwide [2](#embr201845986-bib-0002){ref-type="ref"}. Most deaths from PC are caused by metastases, especially in bone [3](#embr201845986-bib-0003){ref-type="ref"}. Bone metastasis is virtually incurable and can lead to pain, pathological fractures, nerve compression syndromes, and hypercalcemia. Current treatments for bone‐metastatic PC are mainly palliative, and the underlying mechanism leading to the bone metastasis of PC remains unclear. Novel therapeutic strategy against bone metastasis of PC is urgently required to improve patient outcomes.

Hydrogen sulfide (H~2~S), a rotten egg‐smelling gas, is a signaling molecule that acts as a critical mediator in multiple physiological processes, including regulation of blood vessel vasodilation [4](#embr201845986-bib-0004){ref-type="ref"}, [5](#embr201845986-bib-0005){ref-type="ref"}, [6](#embr201845986-bib-0006){ref-type="ref"}, cardiac response to ischemia/reperfusion injury [7](#embr201845986-bib-0007){ref-type="ref"}, and inflammation [8](#embr201845986-bib-0008){ref-type="ref"}. H~2~S modulates diverse cellular processes mainly by modifying specific cysteine residues in proteins through the formation of a persulfide (‐SSH) bond; this modification is called protein sulfhydration [9](#embr201845986-bib-0009){ref-type="ref"}.

H~2~S is produced endogenously as a metabolite with cystathionine β‐synthase (CBS), cystathionine γ‐lyase (CTH), and 3‐mercaptopyruvate sulfurtransferase (3MST). CBS catalyzes H~2~S by a beta‐replacement reaction with cysteine [10](#embr201845986-bib-0010){ref-type="ref"}, while CTH produces H~2~S from cysteine and water through alpha and beta elimination. In higher concentration of homocysteine, CTH also generates homolanthionine and H~2~S from two homocysteines by gamma‐replacement reactions [11](#embr201845986-bib-0011){ref-type="ref"}. Other than CBS and CTH, 3MST produces H~2~S by processing 3‐mercaptopyruvate (3MP), a metabolite catalyzed from L‐ and D‐cysteine by cysteine aminotransferase (CAT) and D‐amino acid oxidase (DAO), respectively [12](#embr201845986-bib-0012){ref-type="ref"}, [13](#embr201845986-bib-0013){ref-type="ref"}, [14](#embr201845986-bib-0014){ref-type="ref"}, [15](#embr201845986-bib-0015){ref-type="ref"}. Endogenous H~2~S derived from these three enzymes plays an influential role on tumor growth in a variety of different cancer types through induction of angiogenesis, regulation of mitochondrial bioenergetics, acceleration of cell cycle progression, and anti‐apoptosis [16](#embr201845986-bib-0016){ref-type="ref"}. Among them, CBS was upregulated in thyroid [17](#embr201845986-bib-0017){ref-type="ref"}, ovarian [18](#embr201845986-bib-0018){ref-type="ref"}, and colon cancers [19](#embr201845986-bib-0019){ref-type="ref"}, [20](#embr201845986-bib-0020){ref-type="ref"}, while CTH promoted cell growth in breast cancer cells [21](#embr201845986-bib-0021){ref-type="ref"} and astrocytoma cells [22](#embr201845986-bib-0022){ref-type="ref"}. Increased expressions of 3MST were observed in colon, lung adenocarcinoma, urothelial cell carcinoma, and oral carcinomas, implying that 3MST may play a role in drug resistance and oxidative damage during cancer progression [23](#embr201845986-bib-0023){ref-type="ref"}. Notably, it remains unclear whether H~2~S affects cancer metastasis.

Nuclear factor‐kappaB (NF‐κB), initially discovered and studied as a major transcription factor of immune and inflammatory functions, contributes in the control of cell proliferation and oncogenesis [24](#embr201845986-bib-0024){ref-type="ref"}. Studies indicate that activation of NF‐κB signaling positively correlates with PC progression, chemoresistance [25](#embr201845986-bib-0025){ref-type="ref"}, PSA recurrence [26](#embr201845986-bib-0026){ref-type="ref"}, [27](#embr201845986-bib-0027){ref-type="ref"}, and metastatic spread [28](#embr201845986-bib-0028){ref-type="ref"}, [29](#embr201845986-bib-0029){ref-type="ref"}. The NF‐κB activation gene signature effectively predicted metastasis‐free survival in patients with PC [30](#embr201845986-bib-0030){ref-type="ref"}, suggesting that genes downstream from NF‐κB may play important roles in promoting PC metastasis. Among them, interleukin (IL)‐1β prompted PC cells to grow into large skeletal lesions in mice [31](#embr201845986-bib-0031){ref-type="ref"} and to mediate cross‐talk between osteoblasts and PC cells [32](#embr201845986-bib-0032){ref-type="ref"}. These observations indicate a potential role of IL‐1β in the bone‐metastatic progression of PC.

The post‐translational modifications of NF‐κB determine the duration and strength of NF‐κB nuclear activity and transcriptional output [33](#embr201845986-bib-0033){ref-type="ref"}. Recent studies revealed that TNF‐α stimulated the transcription of CTH and H~2~S subsequently generated sulfhydration on cysteine‐38 of the p65 subunit of NF‐κB, resulting in the transcriptional activation of NF‐κB and expression of several anti‐apoptotic genes [34](#embr201845986-bib-0034){ref-type="ref"}. This sulfhydration modification on the p65 subunit appears to be an important mechanism in modulating NF‐κB transcriptional activities.

In the present study, we investigated the role of CTH and its derivative product, H~2~S, in PC progression and metastasis. Our study showed that the expression of CTH increased the H~2~S level, resulting in the activation of NF‐κB‐mediated IL‐1β signaling to instigate cell invasion by sulfhydration on cysteine‐38 of the NF‐κB p65 subunit. The orthotopic implantation study showed that knockdown of CTH in PC3 cells resulted in the suppression of primary tumor growth and lower incidence of lymph node and bone metastasis, while overexpression of CTH in DU145 cells promoted primary tumor growth and increased incidence of lymph node metastasis. Moreover, increased expression of CTH correlated with PC progression and poor survival of the patients. Overall, our current study identified CTH and its derivative H~2~S as potential therapeutic modalities in the intervention of PC progression and distant metastasis.

Results {#embr201845986-sec-0002}
=======

Expression of CTH was upregulated in bone‐metastatic PC cells {#embr201845986-sec-0003}
-------------------------------------------------------------

To elucidate the differential expression of genes during PC metastasis, we established paired PC3‐derived cell lines isolated and established from tumor cells in bone marrow and from primary tumors, respectively, using xenograft orthotopic implantation mouse model [35](#embr201845986-bib-0035){ref-type="ref"}. Briefly, PC3 cells were injected into the ventral portion of the prostate in nude mice and allowed 40 days for the growth of the primary tumor and potential distant metastasis. We then cultured tumor cells isolated from the primary prostate tumors as the "tumor‐derived PC3 cells" or T lines, as well as tumor cells from thigh bone marrows to obtain the "bone‐metastatic PC3 cells" or B lines. Seven paired PC3 B and T lines were thus established from bone marrows and primary tumors, respectively, from seven PC3 tumor‐bearing nude mice. To identify genes involved in prostate cancer metastasis, we subsequently compared expression profiles between these paired cell lines. We found an enzyme, cystathionine γ‐lyase (CTH), was upregulated in five of seven pairs of bone‐metastatic PC3 cells from microarray analysis (Fig [EV1](#embr201845986-fig-0001ev){ref-type="fig"}A), and protein expression of CTH among these pairs was validated by Western blot analysis (Fig [EV1](#embr201845986-fig-0001ev){ref-type="fig"}B). To explore the biological role of CTH in PC, we examined the CTH expression levels in different PC cell lines (Fig [EV1](#embr201845986-fig-0001ev){ref-type="fig"}C). Consistent with previous studies [36](#embr201845986-bib-0036){ref-type="ref"}, the CTH level was absent in the prostate epithelial cell line, RWPE‐1, but was detectable in all other PC cell lines tested, including LNCaP, C4‐2, PC3, 22Rv1, and DU‐145.

![CTH level is elevated in metastatic prostate cancer cells and correlates with poor survival in other cancer types\
AMicroarray analysis showing CTH mRNA expression in seven pairs of PC3 cells grown in bone marrow (B line), compared to cells grown in the orthotopic implanted prostate tumor (T line). The fold changes indicated each T line to B line of CTH expression.BWestern blot analysis of CTH expression in seven pairs of PC3‐B lines and PC3‐T lines.CWestern blot analysis of CTH expression in prostate normal epithelial cells, RWPE‐1, together with five prostate cancer cells, including LNCaP, C4‐2, PC3, 22RV1, and DU145 cells.DWestern blot analysis of CTH, CBS, and 3MST expression in PC3‐T2, PC3‐B2, PC3‐T3, and PC3‐B3 lines.E, FTotal glutathione (GSH) content and the ratio of reduced glutathione to oxidized glutathione (GSH/GSSG). Cells were seeded at a density of 5 × 10^3^ cells per 96‐well plate overnight; then, cells were lysed to measure the GSH and GSSG levels. Data indicate total glutathione concentration normalized to total protein content (E) and the ratio of GSH to GSSG normalized to total protein content (F). Data shown represent the normalized means ± SD (*n* = 3 biological replicates).G, HAssociation of CTH expression with poor survival in pancreatic adenocarcinoma (PAAD) and lower grade glioma (LGG). Kaplan--Meier survival analysis of PAAD (G) and LGG (H) patients with high or low CTH expression. The RNA‐seq data of CTH were downloaded from the TCGA database as described in the section of Materials and Methods. The statistical significance was determined using the chi‐square test.\
Source data are available online for this figure.](EMBR-20-e45986-g003){#embr201845986-fig-0001ev}

To explore the functional relevance of CTH in PC, two pairs of bone‐metastatic (PC3‐B2 or PC3‐B3) versus primary tumor‐derived (PC3‐T2 or PC3‐T3) PC3 cells were selected. We observed that bone‐metastatic PC3 cells exhibited substantially higher migration and invasion abilities (Fig [1](#embr201845986-fig-0001){ref-type="fig"}A), but the cell proliferation rate remained similar between the B and T lines (Fig [1](#embr201845986-fig-0001){ref-type="fig"}B). The expression of CTH and its enzymatic gaseous product, hydrogen sulfide (H~2~S), was increased in PC3‐B2 and PC3‐B3 cells, as compared with PC3‐T2 and PC3‐T3 cells (Fig [1](#embr201845986-fig-0001){ref-type="fig"}C and D). More importantly, to determine whether B lines exhibited higher metastatic potential than T lines, we re‐inoculated PC3‐B2, PC3‐B3, and PC3‐T2 and PC3‐T3 cells orthotopically into the prostates in nude mice. Our data indicated that PC3‐B2 and PC3‐B3 exhibited higher metastatic potential than PC3‐T2 and PC3‐T3 cells (Fig [1](#embr201845986-fig-0001){ref-type="fig"}E and F, [Appendix Fig S1](#embr201845986-sup-0001){ref-type="supplementary-material"}), indicating that PC3‐B2 and PC3‐B3 cells gained increased migratory ability to disseminate to distant organs such as paraaortic lymph nodes and bone marrow and grew into micro‐ or macrometastatic tumors, whereas PC3‐T2 and PC3‐T3 cells had much less ability to do so. We further examined protein expressions of the other two H~2~S producing enzymes, CBS and 3MST, in PC3‐B2 and PC3‐B3 cells. In contrast to the results with CTH, the expressions of CBS and 3MST remained similar in PC3‐B2 and PC3‐B3 cells (Fig [EV1](#embr201845986-fig-0001ev){ref-type="fig"}D). Since CTH is a key enzyme for glutathione (GSH) biosynthesis, we also checked whether the oxidative stress by GSH increased in PC3‐B lines. Both total GSH levels and the glutathione disulfide (GSSG)/GSH ratio remained unchanged in PC3‐B2 and PC3‐B3 cells, as compared with PC3‐T2 and PC3‐T3 cells (Fig [EV1](#embr201845986-fig-0001ev){ref-type="fig"}E and F), suggesting that redox homeostasis is not affected in bone‐metastatic PC3 cells.

![Expression of CTH increases in bone‐metastatic PC3 cells and positively correlates with PC progression and poor survival\
AComparison of migration and invasion abilities between T and B lines. PC3 T and B line cells were incubated for migration (16 h) and invasion (24 h) assay. Data shown represent the means ± SD (*n* = 3 biological replicates). Student\'s *t*‐test was used for the statistical analysis (\**P* \< 0.05; \*\**P* \< 0.01).BComparison of cell proliferation rate between T and B lines. Cell proliferation assay was performed by MTS reagents. Data are the means ± SD (*n* = 3 biological replicates).CWestern blot analysis of the endogenous CTH in PC3 orthotopically implanted primary tumor‐derived (T2 and T3 lines) and bone metastasis‐derived cancer cells (B2 and B3 lines).DTop: H~2~S catalyzing activity of cell lysates from PC3‐T2, PC3‐B2, PC3‐T3, and PC3‐B3 lines. Lead acetate‐soaked paper strips show a PbS brown stain as a result of reaction with H~2~S. Bottom: The level of H~2~S production was quantified by densitometry, and the histograms represent the means ± SD (*n* = 3 biological replicates). ANOVA followed by Tukey\'s post hoc test was used for the statistical analysis (\**P* \< 0.05).E, F1 × 10^6^ PC3‐T2, PC3‐B2, PC3‐T3, and PC3‐B3 cells were orthotopically injected into mouse prostate for 15--20 days. Incidences of paraaortic lymph nodes metastasis (E) and bone metastasis (F) are shown (*n* = 6--8 mice per group). Student\'s *t*‐test was used for the statistical analysis (\**P* \< 0.05; \*\**P* \< 0.01).GTop: The expression of CTH in prostate tumors by immunocytochemistry analysis of commercial tissue arrays. Samples were sub‐grouped by TNM stages. The representative images from different stages are shown. S: stroma; Scale bars: 250 μm. Bottom: The statistical significance was determined using the chi‐square testH, IThe RNA‐seq data of CTH were downloaded from the TCGA database as described in the section of Materials and Methods. (H) The mRNA expression of CTH in PC specimens and normal tissues. Data are presented as means ± SD (*n* = 50 cases for adjacent non‐tumor parts and 469 cases for PC tumors). Student\'s *t*‐test was used for the statistical analysis (\*\**P* \< 0.01). (I) Kaplan--Meier survival analysis of PC patients with high or low CTH expression. The statistical significance was determined using the chi‐square test.\
Source data are available online for this figure.](EMBR-20-e45986-g002){#embr201845986-fig-0001}

Increased expression of CTH correlated with progression and poor survival in PC {#embr201845986-sec-0004}
-------------------------------------------------------------------------------

To examine the expression of CTH during PC progression, we evaluated CTH expression in PC specimens with defined stages and grades using immunohistochemistry and a tumor TNM staging system for grouping. The evaluations included 105 primary prostate tumors and 11 adjacent non‐tumors. The staining intensities correlated well with the PC stage (Fig [1](#embr201845986-fig-0001){ref-type="fig"}G). The expression of CTH in primary tumors increased considerably in patients with advanced stages (III/IV), as compared with the adjacent non‐tumor tissue or early‐stage tumors (I/II; Fig [1](#embr201845986-fig-0001){ref-type="fig"}G). To explore the clinical significance of CTH, we analyzed the correlation of CTH expression with overall survival from the TCGA PC RNA‐seq datasets. A total of 469 PC and 50 normal tissue specimens were included. Our analysis revealed that CTH expression substantially increased in PC tissues, as compared with the normal tissues (Fig [1](#embr201845986-fig-0001){ref-type="fig"}H). More importantly, analysis from PC patients with 8 years of follow‐up revealed a significant correlation between high CTH expression and poor survival (Fig [1](#embr201845986-fig-0001){ref-type="fig"}I), indicating the prognostic potential of CTH in PC. Concordantly, the association between CTH expression and poor survival was also observed in pancreatic adenocarcinoma (PAAD) and lower grade glioma (LGG) from the TCGA RNA‐seq datasets (Fig [EV1](#embr201845986-fig-0001ev){ref-type="fig"}G and H), implying that CTH may play a crucial role during cancer progression in various cancer types.

CTH promoted PC cell migration and invasion, but not proliferation {#embr201845986-sec-0005}
------------------------------------------------------------------

We next investigated the role of CTH in PC progression. Overexpression of CTH from the pCMV‐CTH‐HA expression plasmid in PC3‐T2 cells resulted in the increased H~2~S production, whereas depletion of CTH by siRNA in PC3‐B2 cells reduced the production of H~2~S (Fig [2](#embr201845986-fig-0002){ref-type="fig"}A and B). Knockdown of CTH significantly suppressed cell migration and invasion in PC3‐B2 cells (Fig [2](#embr201845986-fig-0002){ref-type="fig"}C). To ensure the specificity of the siRNA, we further confirmed that depletion of CTH by two different siRNAs significantly suppressed cell migration and invasion in PC3‐B2 and PC3‐B3 cells, while re‐expression of CTH successfully rescued reduced cell migration and invasion upon knockdown of CTH (Fig [EV2](#embr201845986-fig-0002ev){ref-type="fig"}A--C). Consistent with Fig [1](#embr201845986-fig-0001){ref-type="fig"}B, the CTH knockdown did not affect the growth rates of PC3‐B2 cells versus those of PC3‐T2 cells (Fig [2](#embr201845986-fig-0002){ref-type="fig"}D). Both migration and invasion abilities were significantly increased in the PC3 cells overexpressing CTH (Fig [2](#embr201845986-fig-0002){ref-type="fig"}E and F), implying a potential role of CTH in cell migration/invasion. Knockdown of CTH in other PC cells lines, including 22Rv1 and C4‐2, also resulted in the suppression of both cell migration and invasion (Fig [EV2](#embr201845986-fig-0002ev){ref-type="fig"}D and E), indicating the role of CTH in cell migration and invasion is common among the PC cell lines tested. Treatment of DL‐propargylglycine (PAG), an irreversible inhibitor for CTH enzyme activity, resulted in the considerably reduced invasion but had no effect on cell migration (Fig [2](#embr201845986-fig-0002){ref-type="fig"}G), suggesting the enzyme activity of CTH is required only for cell invasion. To further confirm whether CTH promoted cell migration is enzyme activity‐independent, we generated CTH mutant with low enzymatic activity. Several polymorphic mutations on CTH are found in patients with cystathioninuria, and mutation on Q240E exhibits \~70‐fold decrease in its kinetic activity [37](#embr201845986-bib-0037){ref-type="ref"}. Our data showed that the expression of this CTH^Q240E^ mutant still induced cell migration in PC3 cells (Fig [EV2](#embr201845986-fig-0002ev){ref-type="fig"}F). However, the cell invasion was reduced in cells expressing this CTH^Q240E^ mutant, as compared to the cells expressing CTH wild type (Fig [EV2](#embr201845986-fig-0002ev){ref-type="fig"}F). Due to the fact that enzymatic activity of CTH is not completely abolished in this Q240E mutant, there existed residual invasion promoting ability in the cells expressing this mutant. Overall, our data indicate that CTH protein promotes cell migration through an enzyme‐independent pathway. In the future, we will try to identify proteins interacting with this CTH^Q240E^ mutant to decipher the unknown mechanism of how CTH promotes cell migration.

![CTH promotes H~2~S production, migration, and invasion\
AWestern blot analysis of the CTH level in PC3‐T2 cells with CTH overexpression by pCMV‐CTH‐HA or PC3‐B2 cells with CTH knockdown by siCTH‐1.BTop: The H~2~S production capacity of cell lysates from PC3‐T2 cells with CTH overexpression by pCMV‐CTH‐HA or PC3‐B2 cells with CTH knockdown by siCTH‐1. Lead acetate‐soaked paper strips show a PbS brown stain as a result of reaction with H~2~S. Bottom: The level of H~2~S production was quantified by densitometry, and the histograms represent the means ± SD (*n* = 3 biological replicates). ANOVA followed by Tukey\'s post hoc test was used for the statistical analysis (\**P* \< 0.05).CPC3‐B2 cells were transfected with control or siCTH‐1 and then were subjected to migration (16 h) and invasion (24 h) assays.DCell proliferation rates of PC3‐B2 cells with CTH knockdown. Cell proliferation assay was performed by MTS reagent.EWestern blot analysis of the CTH levels in PC3 cells transfected with HA‐CTH or pCMV‐HA vector control.FPC3 cells were transfected with HA‐CTH or pCMV‐HA vector control and then incubated for migration (16 h) and invasion assay (24 h).GPC3 cells were pre‐treated with 10 μM PAG for 16 h, and incubated for migration (16 h) and invasion assay (24 h) in the presence of 10 μM PAG.Data information: (C, D, F, and G) Data shown represent the means ± SD (*n* = 3 biological replicates). Student\'s *t*‐test was used for the statistical analysis (\**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001).Source data are available online for this figure.](EMBR-20-e45986-g004){#embr201845986-fig-0002}

![CTH expression stimulates cell migration and invasion in prostate cancer cells\
A, BPC3‐B2 and PC3‐B3 cells were transfected with control siRNA, siCTH‐1, 2, or pCMV‐CTH‐HA, and then incubated for migration (A) and invasion assay (B). Data shown represent the normalized means ± SD (*n* = 3 biological replicates). ANOVA followed by Tukey\'s post hoc test was used (\*\*\**P* \< 0.001).CWestern blot analysis of the CTH levels in PC3‐B2 and PC3‐B3 cells transfected with control siRNA, siCTH‐1, 2, or pCMV‐CTH‐HA.D, E22Rv1 and C4‐2 cells were transfected with control or siCTH‐1 and then were subjected to migration (D) and invasion (E) assays. Data shown represent the means ± SD (*n* = 3 biological replicates). Student\'s *t*‐test was used for the statistical analysis (\**P* \< 0.05; \*\*\**P* \< 0.001).FPC3 cells were transfected with HA‐CTH, HA‐CTH^Q240E^, or pCMV‐HA vector control and then incubated for migration and invasion assay. Data shown represent the means ± SD (*n* = 3 biological replicates). ANOVA followed by Tukey\'s post hoc test was used (\*\**P* \< 0.01; \*\*\**P* \< 0.001).\
Source data are available online for this figure.](EMBR-20-e45986-g005){#embr201845986-fig-0002ev}

Knockdown of CTH suppressed cell invasion through inhibition of NF‐κΒ‐IL‐1β‐mediated signaling {#embr201845986-sec-0006}
----------------------------------------------------------------------------------------------

The previous study demonstrated that cell survival prompted by NF‐κΒ was mediated through sulfhydration of the p65 subunit [34](#embr201845986-bib-0034){ref-type="ref"}. We also observed increased endogenous p65 sulfhydration in PC3‐B2 or PC3‐B3 cells, as compared with PC3‐T2 or PC3‐T3 cells, while depletion of CTH by siRNA in PC3‐B3 cells reduced the sulfhydration of p65 (Fig [EV3](#embr201845986-fig-0003ev){ref-type="fig"}A). To determine whether NF‐κΒ sulfhydration is required for PC progression, we assessed the gene expression profile downstream from the NF‐κΒ‐mediated signaling. Among them, IL‐1β, one of the pro‐inflammatory cytokines, was significantly inhibited in PC3 cells with CTH knockdown (Fig [3](#embr201845986-fig-0003){ref-type="fig"}A). IL‐1β is known to play a positive autoregulatory loop through NF‐κΒ‐mediated signaling [38](#embr201845986-bib-0038){ref-type="ref"}. By adding human recombinant IL‐1β to the culture medium, the reduced expression of IL‐1β mRNA by CTH knockdown was restored (Fig [3](#embr201845986-fig-0003){ref-type="fig"}A). Secreted IL‐1β protein in the culture medium was reduced in PC3 cells with CTH knockdown (Fig [3](#embr201845986-fig-0003){ref-type="fig"}B). More importantly, decreased cell invasion in PC3 cells with CTH knockdown was restored by treatment with recombinant IL‐1β (Fig [3](#embr201845986-fig-0003){ref-type="fig"}C), suggesting that the decreased cell invasion by CTH knockdown was likely due to blockage of the IL‐1β production.

![Knockdown of CTH decreases IL‐1β‐stimulated p65 nuclear translocation\
AUpper: PC3‐T2, PC3‐B2, PC3‐T3, PC3‐B3 cells or PC3‐B3 cells with CTH or control siRNA transfection were subjected to the modified biotin switch assay with the antibody against p65 to detect S‐sulfhydration. Bottom: Quantitative analysis of SSH‐p65 protein level, and normalized with total p65 level. Histograms represent normalized means ± SD (*n* = 3 biological replicates). Student\'s *t*‐test was used for the statistical analysis (\*\**P* \< 0.01; \*\*\**P* \< 0.001).BPC3 cells were treated with 20 ng/ml IL‐1β for 1 h after 48 h post‐transfection. Cells were then subject to fractionation, and the extracts from the nuclear and cytoplasmic compartments were analyzed by Western blotting using the indicated antibodies. Lamin B2 and tubulin serve as the marker of the nuclear and cytoplasmic compartments, respectively. T: total, N: nuclear fraction, and C: cytoplasmic fraction.CQuantitative analysis of the cellular fractionation results from (B). The p65 nuclear protein level was normalized with p65 level in the total cell lysate. Histograms represent means ± SD (*n* = 3 biological replicates). ANOVA followed by Tukey\'s post hoc test was used for the statistical analysis (\**P* \< 0.05; \*\**P* \< 0.01).DThe expression of CTH upon IL‐1β stimulation. PC3 cells were treated with 20 ng/ml IL‐1β for 24 h at 48 h post‐transfection with siCTH. Cell lysates were then analyzed by Western blotting using an antibody against CTH.EUpper: PC3 cells treated with 20 ng/ml IL‐1β for 24 h were subjected to the modified biotin switch assay with the antibody against p65 to detect S‐sulfhydration. PC3 cells treated with 1 μM NaHS for 1 h were used as positive control. Bottom: Histograms represent normalized means ± SD (*n* = 3 biological replicates). ANOVA followed by Tukey\'s post hoc test was used for the statistical analysis (\*\**P* \< 0.01).\
Source data are available online for this figure.](EMBR-20-e45986-g007){#embr201845986-fig-0003ev}

![CTH regulates cell invasion through IL‐1β/NF‐κB pathway\
AReal‐time RT--PCR analysis for IL‐1β mRNA levels in PC3 cells with control or CTH knockdown. Recombinant IL‐1β (10 ng/ml) was added for 24 h in serum‐free medium.BELISA assay for IL‐1β protein level in the culture medium of PC3 cells with control or CTH knockdown.CPC3 cells transfected with control or CTH knockdown were incubated for invasion (24 h) assay with recombinant IL‐1β (10 ng/ml) added to the medium of the lower chamber.DPC3 cells transfected with control or CTH siRNA were exposed to IL‐1β (20 ng/ml) for 1 h. Subcellular localization of p65 was detected by immunocytochemistry. Nuclei were counterstained with DAPI. The representative images are shown. Scale bars: 25 μm.EThe percent of nuclear translocation for p65 was scored by counting the number of nuclear positive stained cells of p65 to the total number of cells in random microscopic fields.F, GReal‐time RT--PCR analysis for VEGF (F) and MMP‐13 (G) mRNA level in PC3 cells with control or CTH knockdown. Recombinant IL‐1β (10 ng/ml) was added for 24 h in serum‐free medium.Data information: All data shown (A--C and E--G) represent the means ± SD (*n* = 3 biological replicates). Student\'s *t*‐test (B) or ANOVA followed by Tukey\'s post hoc test (A, C, and E--G) was used for the statistical analysis. (\**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001).](EMBR-20-e45986-g006){#embr201845986-fig-0003}

Nuclear localization of the p65 subunit is commonly used as a parameter of activation in the NF‐κB‐mediated pathway [39](#embr201845986-bib-0039){ref-type="ref"}. To assess whether CTH affects NF‐κB transcriptional activities, translocation of the p65 subunit was monitored by immunostaining. IL‐1β stimulation caused nuclear translocation of the p65 subunit in almost sixty percent of the PC3 cell population, while the percent of cells with nuclear translocation decreased to a basal level in IL‐1β stimulated cells with CTH knockdown (Fig [3](#embr201845986-fig-0003){ref-type="fig"}D and E). The reduced nuclear translocation by IL‐1β in CTH knockdown cells was further confirmed by subcellular fractionation of cytosol and nuclei (Fig [EV3](#embr201845986-fig-0003ev){ref-type="fig"}B and C). These observations suggest that CTH mediates NF‐κB transcriptional activities through regulating p65 nuclear translocation. In addition, treatment of IL‐1β did not change the expression of CTH (Fig [EV3](#embr201845986-fig-0003ev){ref-type="fig"}D), as well as p65 sulfhydration (Fig [EV3](#embr201845986-fig-0003ev){ref-type="fig"}E), suggesting that the sulfhydration of p65 is not stimulated by IL‐1β‐mediated signaling pathway.

Previous studies showed that both vascular endothelial growth factor (VEGF) and collagenase‐3 (MMP‐13) were upregulated by IL‐1β stimulation [40](#embr201845986-bib-0040){ref-type="ref"}, [41](#embr201845986-bib-0041){ref-type="ref"}. We found that both VEGF mRNA expression and MMP‐13 mRNA expression were significantly inhibited in PC3 cells with CTH knockdown, and treatment of IL‐1β partially restored these reductions (Fig [3](#embr201845986-fig-0003){ref-type="fig"}F and G), indicating the possible involvement of VEGF and MMP‐13 in CTH‐mediated signaling pathways.

The H~2~S‐mediated sulfhydration of the NF‐κB p65 subunit resulted in increased IL‐1β production and enhanced cell invasion {#embr201845986-sec-0007}
---------------------------------------------------------------------------------------------------------------------------

To determine whether the CTH catalyzed product, H~2~S, was involved in cell migration and invasion, sodium hydrosulfide (NaHS), or GYY4137, the donor of H~2~S, was applied. In contrast to the rapid production of H~2~S by NaHS, GYY4137 serves as a slow‐releasing donor of H~2~S [42](#embr201845986-bib-0042){ref-type="ref"}. Consistent with the previous observation, that only cell invasion requires the enzyme activity of CTH (Fig [2](#embr201845986-fig-0002){ref-type="fig"}G), treatment with NaHS in a concentration range between 10 nM and 100 μM induced only cell invasion but not cell migration in PC3 cells (Fig [4](#embr201845986-fig-0004){ref-type="fig"}A), and the same phenomenon was observed in 22Rv1 and C4‐2 cells (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}A). Treatment with GYY4137 (1--10 μM) also significantly increased cell invasion in PC3 cells (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}B). The concentration of NaHS for maximal stimulation appeared to be between 10 nM and 10 μM. Dosages higher than 100 μM showed no effect on invasion (see Discussion). We further determined that reduced cell invasion by CTH knockdown in PC3 cells was abrogated in the presence of NaHS (Fig [4](#embr201845986-fig-0004){ref-type="fig"}B), confirming that the CTH promotion of cell invasion was largely through H~2~S production. We then measured sulfhydration of p65 by modified biotin switch assay. Our data indicated that sulfhydration of p65 (‐SSH) was increased in the presence of NaHS, and this sulfhydration was depleted by dithiothreitol (DTT) (Fig [4](#embr201845986-fig-0004){ref-type="fig"}C), suggesting that the p65 modification by NaHS is S‐S bond. Treatment of NaHS from 10 nM to 10 μM induced the highest levels of p65 sulfhydration in PC3 cells (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}C), implying that only small amount of H~2~S, as low as 10 nM, is sufficient to induce sulfhydration of p65, resulting in the promotion of cell invasion (Fig [4](#embr201845986-fig-0004){ref-type="fig"}A). Cells with positive nuclear staining of the p65 subunit increased to approximately forty percent in the presence of NaHS, as compared with the population of untreated cells (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}D and E). Moreover, serum‐induced p65 nuclear translocation was reduced by CTH knockdown, and this reduction was restored in the presence of NaHS in PC3 cells ([Appendix Fig S2](#embr201845986-sup-0001){ref-type="supplementary-material"}). Treatment of NF‐κB‐specific inhibitors, SN50 and QNZ, attenuated NaHS and GYY4137‐induced cell invasion (Figs [4](#embr201845986-fig-0004){ref-type="fig"}D and [EV4](#embr201845986-fig-0004ev){ref-type="fig"}F), confirming our hypothesis that H~2~S‐mediated cell invasion was due to NF‐κB activation and its subsequent signaling pathways. The gene expression levels of IL‐1β, MMP‐13, and VEGF were substantially upregulated in the presence of NaHS (Fig [4](#embr201845986-fig-0004){ref-type="fig"}E). Secreted IL‐1β protein in the culture medium was also induced in PC3 cells treated with NaHS (10 nM--10 μM; Fig [4](#embr201845986-fig-0004){ref-type="fig"}F). Meanwhile, consistent with previous the observation that H~2~S mediated gene expression was due to coactivator ribosomal protein S3 (RPS3) [34](#embr201845986-bib-0034){ref-type="ref"}, knockdown of RPS3 suppressed the expression levels of H~2~S‐induced genes, including IL‐1β, MMP‐13, and VEGF (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}G). Together, our data suggested that H~2~S produced by CTH promoted cell invasion through IL‐1β‐NF‐κB‐mediated signaling pathways.

![H~2~S promotes cell invasion through IL‐1β/NF‐κB pathway\
APC3 cells were incubated for migration (16 h) and invasion (24 h) assay. DMEM/10% FBS, together with various concentration of NaHS (10 nM--1 mM) acting as a chemoattractant.BPC3 cells transfected with control or CTH siRNA were incubated for invasion (24 h) assay. DMEM/10% FBS, with or without NaHS (1 μM), acting as a chemoattractant.CTop: PC3 cells treated with 100 μM NaHS for 30 min at 37°C. Cells were lyzed and treated with or without DTT for 10 min at 4°C before subjecting to the modified biotin switch assay with the antibody against p65 to detect S‐sulfhydration. Down: Quantitative analysis of SSH‐p65 protein level and normalized with total p65 level.DPC3 cells were incubated for invasion assay for 24 h. DMEM/10% FBS, together with 1 μM NaHS and an NF‐κB inhibitor (50 μg/ml SN50, or 100 nM QNZ), acting as a chemoattractant.EReal‐time RT--PCR analysis for IL‐1β, VEGF, and MMP‐13 mRNA levels in PC3 cells treated with 1 μM NaHS for 24 h.FELISA assay for IL‐1β protein level in the culture medium of PC3 cells with various concentrations of NaHS (10 nM--10 μM) added for 24 h.GWestern blot analysis of the p65 expression in PC3 cells with p65 knockout and then transfected with p65 wild‐type or C38S mutant.HPC3 cells with p65 knockout with or without overexpression of p65 wild‐type or C38S mutant were incubated for invasion assay for 24 h. DMEM/10% FBS was used as a chemoattractant.I--K1 × 10^6^ PC3 cells with p65 knockout were transiently re‐expressed p65 wild‐type or C38S mutant and inoculated into the bloodstream via tail‐vein injection. After 7 days of inoculation, mouse lung was collected to examine lung metastasis. (I) Images show H&E staining of the lungs from mice injected with p65 knockout PC3 cells re‐expressing p65 wild‐type or C38S mutant. Red arrows indicate metastatic nodules. Scale bar: 1 mm. (J, K) The total metastatic nodules per lung (J) and the percentage of the metastatic area per lung (K) were quantified. Data are presented as means ± SEM (*n* = 7 mice per group). Student\'s *t*‐test was used for the statistical analysis (\**P* \< 0.05).Data information: (A--H) Data shown represent the means ± SD (*n* = 3 biological replicates). Student\'s *t*‐test (E) or ANOVA followed by Tukey\'s post hoc test (A--D, F, and H) was used for the statistical analysis (\**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001).Source data are available online for this figure.](EMBR-20-e45986-g008){#embr201845986-fig-0004}

![Treatment of H~2~S induces PC3 cell invasion through NF‐κB‐mediated signaling pathways\
A22Rv1 and C4‐2 cells were incubated for invasion assay for 16--18 h. DMEM/10% FBS, together with 1 μM NaHS served as a chemoattractant.BPC3 cells were incubated for invasion assay for 24 h. DMEM/10% FBS, together with 1 or 10 μM GYY4137, served as a chemoattractant.CTop: PC3 cells treated with 1 nM--1 mM NaHS for 1 h were subjected to the modified biotin switch assay with the antibody against p65 to detect S‐sulfhydration. Bottom: Quantitative analysis of SSH‐p65 protein level, and normalized with total p65 level.DPC3 cells were treated with 1 μM NaHS for 24 h in the absence of serum. Subcellular localization of p65 was detected by immunocytochemistry. Nuclei were counterstained with DAPI. Scale bar: 25 μm.ENuclear translocation of p65 was scored by counting the number of nuclear positive stained cells of p65 to the total number of cells in random microscopic fields.FPC3 cells were incubated for invasion assay for 24 h. DMEM/10% FBS, together with 1 μM GYY4137 and NF‐κB inhibitors (50 μg/ml SN50, or 100 nM QNZ), served as a chemoattractant.GReal‐time RT--PCR analysis for IL‐1β, MMP‐13, VEGF, and RPS3 mRNA level in PC3 cells with control or RPS3 knockdown.HLeft: PC3 cells with p65 knockout with p65 C38S mutant and PC3 parental cells were treated with 100 μM NaHS for 1 h and subjected to the modified biotin switch assay with the antibody against p65 to detect S‐sulfhydration. Right: Quantitative analysis of SSH‐p65 protein level, and normalized with total p65 level.IPC3 cells with p65 knockout were transfected with vector, p65 wild‐type, or p65 C38S mutant and then exposed to IL‐1β (20 ng/ml) for 1 h. Subcellular localization of p65 was detected by immunocytochemistry. Nuclei were counterstained with DAPI. The representative images are shown. Scale bars: 10 μm.JNuclear translocation of p65 was scored by counting the nuclear positive stained cells and the total number of cells quantified in random microscopic fields.Data information: (A--C, E--H, J) Data shown represent the means ± SD (*n* = 3 biological replicates). Student\'s *t*‐test (A, E, G) or ANOVA followed by Tukey\'s post hoc test (B, F, H, I) was used for statistical analysis (\**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001).Source data are available online for this figure.](EMBR-20-e45986-g009){#embr201845986-fig-0004ev}

To determine whether sulfhydration of the NF‐κB p65 subunit on cysteine 38 [34](#embr201845986-bib-0034){ref-type="ref"} is required for CTH/H~2~S‐mediated cell invasion, we established PC3 cell lines with CRISPR/Cas9‐mediated knockout (KO) of p65 followed by re‐expression of p65^wild‐type^ or p65^C38S^ mutant by transient transfection (Fig [4](#embr201845986-fig-0004){ref-type="fig"}G). The p65^wild‐type^ or p65^C38S^ mutant was made with the in‐frame mutation to replace sgRNA recognizing nucleotides, allowing these constructs to translate correctly and efficiently in the p65 KO PC3 cells. We then confirmed that sulfhydration of p65 was abolished in p65^C38S^ mutant in the presence of NaHS (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}H). Depletion of p65 attenuated NaHS‐induced cell invasion (Fig [4](#embr201845986-fig-0004){ref-type="fig"}H), indicating that H~2~S‐mediated cell invasion was due to NF‐κB activation. Moreover, re‐expression of p65^wild‐type^, but not p65^C38S^ mutant, restored invasion abilities (Fig [4](#embr201845986-fig-0004){ref-type="fig"}H), suggesting the sulfhydration site on cysteine 38 was required for p65‐mediated cell invasion. Moreover, nuclear translocation of p65 was observed in the p65 KO PC3 cells with re‐expression of the p65^wild‐type^, but not the p65^C38S^ mutant, in the presence of IL‐1β (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}I and J). Our data indicated that sulfhydration on the cysteine 38 of the NF‐κB p65 subunit was required for its nuclear translocation and subsequent cell invasion ability. To examine whether p65 sulfhydration on cysteine 38 was involved in the progression of prostate cancer metastasis, we transiently transfected p65^wild‐type^ or p65^C38S^ mutant in p65 KO PC3 cells, and then, those cells were inoculated into the mice via tail‐vein injection. The p65 KO PC3 cells with the p65^C38S^ mutant re‐expression showed decreased number of lung‐metastatic nodules (Fig [4](#embr201845986-fig-0004){ref-type="fig"}I and J) and reduced percentage of lung‐metastatic area (Fig [4](#embr201845986-fig-0004){ref-type="fig"}I and K), as compared to the p65^wild‐type^ re‐expression group, suggesting that p65 sulfhydration could be directly involved in the promotion of cancer metastasis.

Knockdown of CTH suppressed tumor growth and reduced the incidence of paraaortic lymph nodes and bone metastases in the mouse orthotopic implantation model {#embr201845986-sec-0008}
-----------------------------------------------------------------------------------------------------------------------------------------------------------

To investigate the role of CTH during PC progression, orthotopic implanted xenografts in nude mice were utilized. PC3 cells stably expressing shCTH or shCon (Fig [5](#embr201845986-fig-0005){ref-type="fig"}A) were orthotopically injected into the prostate capsules of nude mice. Mice were dissected 60 days after injection. In the CTH knockdown group, both tumor weight and tumor size decreased substantially to about 50% of those found in the shCon group (Fig [5](#embr201845986-fig-0005){ref-type="fig"}B and C; [Appendix Fig S3A](#embr201845986-sup-0001){ref-type="supplementary-material"}). Meanwhile, the mouse weight slightly dropped in the shCon group ([Appendix Fig S3B](#embr201845986-sup-0001){ref-type="supplementary-material"}). We then checked the incidence of paraaortic lymph node metastases through histological evaluation. Metastases in paraaortic lymph nodes were observed in 80% of mice in the shCon group compared with only 40% in the shCTH group (Fig [5](#embr201845986-fig-0005){ref-type="fig"}D). Most of the paraaortic lymph nodes were enlarged ([Appendix Fig S3C](#embr201845986-sup-0001){ref-type="supplementary-material"}) and located inside the lymph node cavity in the shCon mice ([Appendix Fig S3D](#embr201845986-sup-0001){ref-type="supplementary-material"}; left panel), while most of the shCTH mice displayed smaller sized lymph nodes ([Appendix Fig S3C](#embr201845986-sup-0001){ref-type="supplementary-material"}) with no metastases found inside the lymph nodes ([Appendix Fig S3D](#embr201845986-sup-0001){ref-type="supplementary-material"}; right panel).

![Knockdown of CTH suppresses tumor growth and distant metastasis in the orthotopic implantation mouse model\
AWestern blot analysis of the CTH expression in PC3 cells stably expressing control or CTH shRNA.B--E1 × 10^6^ PC3 cells with control or CTH knockdown were orthotopically injected into the mouse prostate for 60 days. The tumor weight (B) and tumor volume (C) were compared. Incidences of paraaortic lymph nodes metastasis (D) and bone metastasis (E) are shown. Data are presented as means ± SEM (*n* = 10 mice per group).FReal‐time RT--PCR analysis for CTH mRNA levels in PC3 orthotopic tumors from shCon or shCTH group. Data shown represent normalized means ± SEM (*n* = 10 mice per group).G, HImmunohistochemical analysis of paraffin‐embedded xenograft prostate tumor using CD31 (G) and LYVE‐1 (H) antibody. The total vessel number per mm^2^ was quantified. Scale bars: 0.1 mm. Data are presented as means ± SEM (*n* = 4--5 mice per group).Data information: (B--H) Student\'s *t*‐test was used for the statistical analysis (\**P* \< 0.05).Source data are available online for this figure.](EMBR-20-e45986-g010){#embr201845986-fig-0005}

After we cultured the cells derived from bone marrow of the mice with orthotopic implantation, PC3 cells were detectable in 2 of 10 mice in the shCon group and undetectable in the shCTH group (Fig [5](#embr201845986-fig-0005){ref-type="fig"}E). Those bone‐derived PC3 cells were resistant to puromycin, confirming their lineage from the original injected PC3 cells that stably expressed puromycin‐resistant plasmid. As expected, the expression levels of CTH in the orthotopically implanted tumors were reduced in the shCTH groups, as compared with the shCon group (Fig [5](#embr201845986-fig-0005){ref-type="fig"}F). In summary, our results indicated that the reduction of CTH expression in PC3 cells decreased tumor growth, as well as paraaortic lymph node and bone metastasis.

To investigate whether CTH is required for PC progression, we stably expressed CTH in DU145 cells. DU145 line was originally derived from brain, and not bone, metastasis [43](#embr201845986-bib-0043){ref-type="ref"}, and the expression level of CTH was much lower in DU145 cells, as compared to other prostate cancer lines (Fig [EV1](#embr201845986-fig-0001ev){ref-type="fig"}C). The control and CTH stable overexpressing lines were established (Fig [EV5](#embr201845986-fig-0005ev){ref-type="fig"}A) and orthotopically injected into the prostate capsules of nude mice. In the CTH overexpressing group, the mouse weight was slightly decreased as compared to the control group (Fig [EV5](#embr201845986-fig-0005ev){ref-type="fig"}B), and tumor size was significantly increased in comparison with the control group (Fig [EV5](#embr201845986-fig-0005ev){ref-type="fig"}C and E). The incidence of paraaortic lymph node metastasis was significantly increased in the CTH group as compared to the control group (Fig [EV5](#embr201845986-fig-0005ev){ref-type="fig"}D, F and G). However, bone metastasis was not detected in either group under our experimental duration. Overall, our data suggest that CTH is capable of promoting tumor growth, as well as lymph node and bone metastasis in certain PC lines such as PC3. However, CTH may be required, but not sufficient, for promoting bone metastasis.

![Prostate orthotopic xenograft of DU145 cells with CTH overexpression induces tumor growth and incidence of paraaortic lymph node metastasis\
AWestern blot analysis of the CTH expression in DU145 cells stably expressing PCDNA or PCDNA‐CTH.B--D1 × 10^6^ DU145 cells with PCDNA or PCDNA‐CTH expression were orthotopically injected into the mouse prostate for 30 days. The mouse weight (B) and tumor volume (C) were compared. Incidences of paraaortic lymph node metastasis (D) are shown. Data in (B, C) are presented as means ± SEM (*n* = 7 or 8 mice per group). Student\'s *t*‐test was used for the statistical analysis (\**P* \< 0.05).E, FImages of the orthotopic xenograft tumor (E) and paraaortic lymph nodes (F) of mice orthotopically implanted with DU145‐PCDNA or CTH cells.GImages show H&E staining of paraaortic lymph node sections. T: metastatic tumor cells (scale bar: 10 μm).\
Source data are available online for this figure.](EMBR-20-e45986-g011){#embr201845986-fig-0005ev}

H~2~S is an endogenous stimulator of angiogenesis by accelerating endothelial cell growth, cell migration, and capillary morphogenesis [44](#embr201845986-bib-0044){ref-type="ref"}. To investigate whether CTH knockdown affects angiogenesis and lymphangiogenesis, we examined the expression of corresponding endothelial cell markers using respective antibodies, anti‐cluster of differentiation 31 (CD31), and anti‐lymphatic vessel endothelial hyaluronan receptor 1 (LYVE‐1), in primary orthotopic tumors with immunohistochemical analysis. Both CD31‐ and LYVE‐1‐positive vessel structures were present in the orthotopic tumors (Fig [5](#embr201845986-fig-0005){ref-type="fig"}G and H). In tumors with CTH knockdown, the numbers of vessel‐like structures revealed by CD31 or LYVE‐1 antibody staining were significantly reduced, as compared with the shCon group (Fig [5](#embr201845986-fig-0005){ref-type="fig"}G and H). Our data suggested that CTH/H~2~S signaling was important for tumor angiogenesis and lymphangiogenesis. Consistent with this *in vivo* observation, HUVEC cells cultured with the conditional medium derived from PC3‐B2 cells with CTH knockdown also showed a considerably lower percentage of tube formation *in vitro* ([Appendix Fig S4](#embr201845986-sup-0001){ref-type="supplementary-material"}).

Discussion {#embr201845986-sec-0009}
==========

In the present study, we identified a signaling cascade mediated by CTH/H~2~S to promote PC progression and metastasis (Fig [6](#embr201845986-fig-0006){ref-type="fig"}). Increased expression of CTH in bone‐metastatic PC cells induced a change in H~2~S level, resulting in the activation of IL‐1β/NF‐κB‐mediated signaling to promote cell invasion, angiogenesis, lymphangiogenesis, tumor growth, and metastasis. Our study implies that H~2~S and its generating enzyme, CTH, may serve as potential therapeutic targets for PC metastasis intervention.

![Current working model of CTH/H~2~S‐mediated signaling in PC progression and distant metastasis\
 ](EMBR-20-e45986-g012){#embr201845986-fig-0006}

Previous studies presented controversial results about H~2~S in cancer progression [16](#embr201845986-bib-0016){ref-type="ref"}. Increased endogenous H~2~S in the malignant cells enhanced tumor cell proliferation, drug resistance, and angiogenesis [18](#embr201845986-bib-0018){ref-type="ref"}, [45](#embr201845986-bib-0045){ref-type="ref"}, while high doses of exogenous H~2~S treatment weakened tumors by suppressing tumor cell growth [46](#embr201845986-bib-0046){ref-type="ref"}. Literature studies described the physiological concentrations of H~2~S within a wide range between 10 nM and 300 μM [47](#embr201845986-bib-0047){ref-type="ref"}. Here, our data indicated that H~2~S could promote cell invasion ability in a concentration range from 10 nM to 100 μM, and higher doses of H~2~S showed no effects on cell invasion, as compared with the control (Fig [4](#embr201845986-fig-0004){ref-type="fig"}A). Consistent with the previous observation that endogenous H~2~S played a role in promoting oncogenesis, our data indicated that H~2~S enhanced cell invasion only at the physiological concentration range.

In this study, we showed that CTH expression promoted both cell migration and invasion (Fig [2](#embr201845986-fig-0002){ref-type="fig"}C and F). However, treatment with H~2~S enhanced only cell invasion but not cell migration (Fig [4](#embr201845986-fig-0004){ref-type="fig"}A). Our data also indicated that treatment with CTH‐specific enzymatic inhibitor, PAG, suppressed only cell invasion (Fig [2](#embr201845986-fig-0002){ref-type="fig"}G). In contrast, the expression of CTH^Q240E^, the mutant form of CTH with lower enzymatic activity [37](#embr201845986-bib-0037){ref-type="ref"}, induced only cell migration, but not cell invasion (Fig [EV2](#embr201845986-fig-0002ev){ref-type="fig"}F), suggesting that the enzyme activity of CTH promoted cell invasion mainly through its derivative product, H~2~S, mediated signaling pathways. Conversely, CTH‐induced cell migration was regulated through an enzyme‐independent pathway. Additional studies are required to unveil the underlying mechanism of how CTH modulates cell migration.

NF‐κB activation requires translocation of NF‐κB subunits, p65 and p50, from the cytosol to the nucleus [48](#embr201845986-bib-0048){ref-type="ref"}, [49](#embr201845986-bib-0049){ref-type="ref"}. Nuclear translocation of the NF‐κB is initiated by the signal‐induced degradation of IκB proteins through activation IκB kinase (IKK). The degradation of IkB thus releases NF‐κB to translocate into the nucleus and activate gene transcriptions [50](#embr201845986-bib-0050){ref-type="ref"}. Here, our data showed that blocking p65 sulfhydration resulted in the attenuation of p65 nuclear translocation induced by IL‐1β (Figs [3](#embr201845986-fig-0003){ref-type="fig"}D and [EV4](#embr201845986-fig-0004ev){ref-type="fig"}I), suggesting sulfhydration of p65 might be involved in the nuclear import of the p65 subunit. We also noticed that treatment with H~2~S alone only induced modest nuclear translocation of p65 (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}D), and this induction is incomparable to the level of IL‐1β‐induced nuclear translocation of p65 (Fig [3](#embr201845986-fig-0003){ref-type="fig"}D). Based on these observations, we believe that p65 sulfhydration by H~2~S is not enough to stimulate the p65 nuclear translocation since NF‐κB complex may still interact with the inhibitory protein IkB. Additional signals, such as IL‐1β, are required to activate IKK through phosphorylation, resulting in the degradation of IkB to release p65. The p65 sulfhydration may be required for the interaction between p65 and nuclear transport proteins to facilitate nuclear import. More research is needed to determine the exact role of p65 sulfhydration in regulating NF‐κB activity.

Although H~2~S is an endogenous stimulator of angiogenesis [44](#embr201845986-bib-0044){ref-type="ref"}, the underlying mechanism remains unclear. Here, we demonstrated that treatment with H~2~S induced the expression of IL‐1β (Fig [4](#embr201845986-fig-0004){ref-type="fig"}E and F). IL‐1β is a known pro‐angiogenic cytokine during cancer progression through induction of VEGF [51](#embr201845986-bib-0051){ref-type="ref"}. Coincidentally, our data also indicated that H~2~S induced VEGF and MMP‐13 expression (Fig [4](#embr201845986-fig-0004){ref-type="fig"}E). Taken together, H~2~S likely stimulates angiogenesis through IL‐1β‐VEGF signaling pathway.

Clinical studies revealed that lymph node metastases usually reflect poor prognosis for PC patients [52](#embr201845986-bib-0052){ref-type="ref"}, and the metastatic routes for PC were often first through lymphatic vessels to the regional lymph nodes. Tumor‐associated lymphangiogenesis, therefore, is crucial to facilitate lymph node metastasis [53](#embr201845986-bib-0053){ref-type="ref"}. Here, we observed that lymphangiogenesis was significantly reduced in CTH knockdown tumors (Fig [5](#embr201845986-fig-0005){ref-type="fig"}H). Simultaneously, we observed lower incidence of paraaortic lymph node metastases in mice bearing tumors with CTH knockdown (Fig [5](#embr201845986-fig-0005){ref-type="fig"}D), implying that reduced lymphangiogenesis by CTH knockdown may result in reduced lymph node metastasis. Overall, our data suggested a novel mechanism whereby CTH/H~2~S may facilitate PC metastasis through enhancing lymphangiogenesis in the tumor microenvironment.

Materials and Methods {#embr201845986-sec-0010}
=====================

Cell culture and transfections {#embr201845986-sec-0011}
------------------------------

The RWPE‐1 and C4‐2 cell lines were kindly provided by Dr. Hsing‐Jien Kung. The PC3, LNCaP, 22Rv1, and DU145 cell lines were obtained from the Bioresource Collection and Research Center (BCRC), Taiwan. RWPE‐1 was maintained in Keratinocyte Serum‐Free Medium (K‐SFM; Invitrogen) with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml human recombinant epidermal growth factor (EGF) at 37°C in 5% CO~2~. LNCaP, C4‐2, 22Rv1, and DU145 were maintained in RPMI 1640 medium (RPMI; Invitrogen) with 10% FBS at 37°C in 5% CO~2~. PC3 cells were maintained in Dulbecco modified Eagle medium (DMEM; Invitrogen) with 10% FBS at 37°C in 5% CO~2~. Plasmids were transfected using TransIT 2020 or TransIT X2 (Mirus Bio), while short interfering RNA (siRNA) was transfected using Lipofectamine RNAiMAX (Invitrogen) or TransIT X2 (Mirus Bio). PC3 cell lines stably expressing control or CTH shRNA were selected using puromycin (Sigma‐Aldrich) and established as mass culture. DU145 cell lines stably expressing PCDNA or PCDNA‐CTH were selected using G418 (Sigma‐Aldrich) and established as mass culture.

Cell knockout and mutagenesis {#embr201845986-sec-0012}
-----------------------------

To generate p65 knockout cells, PC3 cells were co‐transfected with pU6‐PGK‐puro‐sgRELA (Sigma‐Aldrich) and p5W‐Cas9.pBsd plasmids (National RNAi Core Facility, Academia Sinica, Taiwan) by a TransIT‐X2 reagent (Mirus). Knockout PC3 cells were selected by using 4 μg/ml blasticidin and 3 μg/ml puromycin and established as mass culture. The p65 subunit of NF‐κB in‐frame mutation (GA[TATC]{.ul}GAGGTGTATTTCACGG) to replace sgRNA recognizing nucleotides (GA[CATT]{.ul}GAGGTGTATTTCACGG) and NF‐κB in‐frame mutation plus C38S mutation plasmid was generated by site‐directed mutagenesis using PfuUltra II Fusion HS DNA polymerase (Agilent Technologies). PCDNA‐p65 was the template plasmid. CTH‐Q240E mutation was generated by site‐directed mutagenesis from the pCMV‐HA‐CTH plasmid. All primer sequences used in this study are provided in [Appendix Table S1](#embr201845986-sup-0001){ref-type="supplementary-material"}.

Nucleotides and reagents {#embr201845986-sec-0013}
------------------------

The CTH‐specific and RPS‐specific siRNAs were purchased from MDBio, Inc (Qingdao, China). The pRFP‐C‐RS‐shCTH construct was purchased from OriGene (Rockville, MD). Detailed siRNA and shRNA sequences are listed in [Appendix Table S1](#embr201845986-sup-0001){ref-type="supplementary-material"}. The full‐length CTH was amplified by RT--PCR of cDNAs from PC3 cells and cloned into pCMV‐HA and PCDNA3.1 vectors. The full‐length p65 was amplified by RT--PCR of cDNAs from PC3 cells and cloned into PCDNA3.1. All primer sequences used in this study are provided in [Appendix Table S1](#embr201845986-sup-0001){ref-type="supplementary-material"}. Antibodies against CTH were purchased from Abnova (Taiwan) or Santa Cruz Biotechnology. Antibodies against CBS, α‐tubulin, GAPDH, and actin were purchased from Santa Cruz Biotechnology. Antibodies against NF‐κB p65 subunit were purchased from Cell Signaling. Anti‐3MST was purchased from GeneTex (Taiwan). Anti‐Lamin B2 was purchased from Millipore. The H~2~S donors, NaHS (for fast release) or GYY4137 (for slow release), were purchased from Sigma‐Aldrich. The CTH inhibitor, DL‐propargylglycine (PAG), was obtained from Cayman Chemical. Human recombinant IL‐1β was obtained from BioLegend. NF‐κB inhibitor, SN50, was obtained from Merck Millipore, and QNZ was obtained from Enzo Life Sciences.

Quantitative real‐time PCR {#embr201845986-sec-0014}
--------------------------

RNA was extracted from cells using TRIzol (Invitrogen) following protocols supplied by the manufacturer. First‐strand cDNA was generated by ReverTra Ace (Toyobo, Japan) using oligo‐dT. Real‐time RT--PCR was performed on a CFX96 real‐time PCR detection system (Bio‐Rad). The KAPA SYBR FAST Universal qPCR Kit (KAPA Biosystems, MA) was used. The mRNA levels were normalized to that of actin. All primer sequences used in this study are provided in [Appendix Table S1](#embr201845986-sup-0001){ref-type="supplementary-material"}. Experiments were repeated at least three times.

H~2~S measurements (lead sulfide method) {#embr201845986-sec-0015}
----------------------------------------

For direct measurement of H~2~S, we leveraged the specific reaction between H~2~S and lead acetate to form a black precipitate (lead sulfide) that could be trapped and visualized on filter paper containing lead acetate [54](#embr201845986-bib-0054){ref-type="ref"}. Briefly, 100--300 μg freeze--thaw homogenate of cells was lysed in a passive lysis buffer (Promega), supplemented with 10 mM Cys and 10 μM PLP. A lead acetate detection paper (Sigma) was placed above the liquid phase in a closed tube and incubated for 2--5 h at 37°C until lead sulfide darkened the paper. The intensity of the lead sulfide deposit was quantified by ImageJ. Data represented as fold changes relative to the control. All experiments were repeated three times. Histograms were the means ± SD from the three independent experiments.

Modified biotin switch (S‐sulfhydration) assay {#embr201845986-sec-0016}
----------------------------------------------

The assay was performed in accordance with a published paper [5](#embr201845986-bib-0005){ref-type="ref"}, with modifications. Briefly, PC3 cells were treated with 1 nM--1 mM NaHS for 30 min at 37°C in culture medium, and then homogenized in a HEN buffer \[250 mM Hepes‐NaOH (pH 7.7), 1 mM EDTA, and 0.1 mM neocuproine\], supplemented with 100 μM deferoxamine, and centrifuged at 13,000 *g* for 30 min at 4°C. Cell lysates (1 mg) were treated with or without 100 μM DTT for 10 min at 4°C. The lysates were then added to a blocking buffer (HEN buffer adjusted to 2.5% SDS and 20 mM MMTS) at 50°C for 20 min with frequent vortexing. The proteins were precipitated by 100% acetone at −20°C for 20 min. After acetone removal, the proteins were resuspended in a HENS buffer (HEN buffer adjusted to 1% SDS), and then, 4 mM biotin‐HPDP (EZ‐link, ThermoFisher) was added. After incubation for 3 h at RT, biotinylated proteins were precipitated by streptavidin agarose beads at 4°C overnight and then washed with the HENS buffer. The biotinylated proteins were analyzed by SDS--polyacrylamide gel electrophoresis and subjected to Western blot analysis with antibodies against NF‐κB p65 subunit (Cell Signaling). All experiments were repeated three times. Histograms were the means ± SD from the three independent experiments.

Nuclear/cytosol fractionation {#embr201845986-sec-0017}
-----------------------------

Cells were washed with ice‐cold PBS twice and harvested in PBS. One‐fourth of the cells were transferred to a new Eppendorf. PBS was removed after centrifuging the cells at 1,500 *g* for 3 min. The total lysate was collected by adding a RIPA lysis buffer (10 mM Tris, pH 7; 150 mM NaCl; 1% Triton X‐100; 1% Na deoxycholate; 1% SDS; 1× protease inhibitor) into one‐fourth of the cells. The remaining cells were lysed by an NP‐40 lysis buffer (1× TBS; 0.5% NP‐40; 1× protease inhibitor). The suspension, containing cytosolic proteins, was transferred into a new Eppendorf. The remaining pellets were washed with an NP‐40 lysis buffer twice and then lysed by a RIPA lysis buffer as a nuclear fraction. Alpha‐tubulin antibody (Santa Cruz Biotechnology) was used as a cytosolic marker, while antibody against Lamin B2 (Millipore) was used as a nuclear marker. All experiments were repeated three times. Histograms were the means ± SD from the three independent experiments.

Western blot analysis {#embr201845986-sec-0018}
---------------------

Cells were lysed in a 10 mM Tris buffer, pH 7.4, containing 0.15 M NaCl, 1% Triton X‐100, 1 mM EDTA, and protease inhibitor mixture (Roche). The cell lysates were resolved in an 8--12.5% SDS‐polyacrylamide gel, transferred onto PVDF membrane and probed with antibodies. All experiments were repeated three times.

Transwell cell migration and cell invasion assay {#embr201845986-sec-0019}
------------------------------------------------

Cell migration and invasion Boyden chamber assays were performed as previously described [55](#embr201845986-bib-0055){ref-type="ref"}, [56](#embr201845986-bib-0056){ref-type="ref"}. Cell migration was assayed in 8.0‐mm Falcon Cell Culture Inserts (Corning), and for the cell invasion assay, the BD BioCoat Matrigel Invasion Chamber was applied (Corning). Briefly, 1 × 10^5^ or 5 × 10^4^ cells were suspended in DMEM (300 μl) and placed in an upper transwell of 0.3 cm^2^ in area. The bottom well was filled with 500 μl DMEM with 10% FBS. After incubation for 16--24 h (Migration) or 24 h (Invasion), cells on the upper side of the inserts were removed by cotton swabs, and cells on the underside were fixed and stained with crystal violet. Photos of three regions were taken from duplicated inserts, and the numbers of cells were counted using ImageJ (NIH, US). All experiments were repeated three times. Data were the means ± SD from the three independent experiments.

Cell proliferation assay {#embr201845986-sec-0020}
------------------------

The cell proliferation assay was measured with CellTiter 96 AQueous One Solution (Promega). The assay was performed according to the methods described in the manufacturer manual. Briefly, cells (1 × 10^3^ cells) were seeded in 96‐well plates and incubated for various times, at defined time points, and 20 μl of CellTiter 96 AQueous One Solution Reagent was added and incubated for 2 h at 37°C. The quantity of formazan product, which is directly proportional to the number of living cells in the culture, was measured by absorbance at 490 nm with a 96‐well plate reader. All experiments were repeated three times. Data were the means ± SD from the three independent experiments.

GSH/GSSG assay {#embr201845986-sec-0021}
--------------

Cells were seeded 5 × 10^3^ at 96‐well overnight then lysed by a glutathione/oxidized glutathione lysis buffer for 30 min at RT. 50 μl cellular lysis was taken for luciferin reaction and detection, which followed the GSH/GSSG‐Glo Assay Kit (Promega) standard protocol. All experiments were repeated three times. Data were the means ± SD from the three independent experiments.

Immunofluorescence {#embr201845986-sec-0022}
------------------

Cells were seeded 1 × 10^4^ on fibronectin‐coated cover‐slides overnight and then cultured at serum‐free (SF) medium for 4 h. For cell signaling activation, 20 ng/ml IL‐1β, 100 μM NaHS, or 10%FBS in SF‐medium was used for 30‐min or 1‐h treatment. Those cover‐slides of cells were washed with PBS, fixed at 4% paraformaldehyde for 30 min and 0.5% Triton X‐100 for 5 min at RT, and then, 20% FBS in PBS solution for 1 h at RT was used for blocking. After fixed and blocking steps, cells were incubated p65 antibody (Cell Signaling; 1:100 dilution) in 1% BSA‐PBS solution at 4°C overnight. The next day, cover‐slides were washed with PBS for three times and stained with Alexa Fluor 488‐coupled antibody (Invitrogen; 1:500 dilution) or DAPI for 1 h at RT; then, cover‐slides were sealed for microscopic observation. Subcellular localization of p65 was detected by immunofluorescence (IF) using antibodies against p65 nuclei were counterstained with DAPI. Images were acquired using confocal microscopy (TCS SP5, Leica). The percentage of cells with positive p65 nuclei staining were counted. At least 25 (Fig [EV4](#embr201845986-fig-0004ev){ref-type="fig"}J) or 50 cells (all the other experiments) per condition were included in each experiment. To avoid bias, all cells imaged from a single field of view were analyzed. All experiments were repeated three times. Data were the means ± SD from the three independent experiments.

Endothelial cell tube formation assay {#embr201845986-sec-0023}
-------------------------------------

HUVEC cells, which spontaneously form capillary tubes when seeded on a Matrigel basement membrane matrix, were used to assay the effects of different conditioned mediums on angiogenesis. To coat the plates with the basement membrane, 50 μl of Matrigel was loaded on each well of a 96‐well dish. 1.5 × 10^4^ HUVEC cells were suspended in cancer cell‐derived conditional mediums or fresh mediums, and then seeded on the solidified Matrigel in a well. After a 16‐h incubation, the network of the tube formed by the cells was photographed for further analysis. The number of tube‐like structures with closed networks of vessel‐like tubes was counted. The quantification of the tube network was based on the number of nodes formed by at least three segments. All experiments were repeated three times. Data were the means ± SD from the three independent experiments.

IL‐1β detection {#embr201845986-sec-0024}
---------------

Culture supernatants from the serum‐free medium of 1 × 10^6^ PC3 cells incubated for 24 h were harvested. The level of IL‐1β released was measured by an ELISA kit in accordance with the manufacturer instructions (eBioscience). All experiments were repeated three times. Data were the means ± SD from the three independent experiments.

Mouse orthotopic implantation and tail‐vein injection model {#embr201845986-sec-0025}
-----------------------------------------------------------

Male athymic BALB/c nude mice were purchased from NLAC, Taiwan, and Bio LASCO Taiwan Co. Eight‐ to twelve‐week‐old male mice were anesthetized with isoflurane and placed in the supine position. 1 × 10^6^ PC3‐T2, B2, T3, and B3 cells, PC3 cells stably expressing CTH or control shRNA, or DU145 cells stably expressing PCDNA or PCDNA‐CTH, in 15ul were mixed with Matrigel in a 1:1 ratio and then injected into the prostate as described [35](#embr201845986-bib-0035){ref-type="ref"}, [57](#embr201845986-bib-0057){ref-type="ref"}. The mice were examined 15--60 days after tumor cell injection. Original tumors, paraaortic lymph nodes (LN), and bone marrow (BM) were harvested for hematoxylin and eosin (H&E) staining or *in vitro* BM culture. For the tail‐vein injection experiment, 1 × 10^6^ PC3 cells with p65 knockout were transiently re‐expressed p65^wild‐type^ or p65^C38S^ and inoculated into the bloodstream via tail‐vein injection. Lung tissues were collected after 1 week of injection for H&E staining. Tissue specimens (LN, prostate tumor, and lung) were fixed, paraffin‐embedded, serially sectioned, and stained with H&E by a pathology core lab (NHRI, Taiwan). The BM cells from mouse thigh bones were collected and cultured in RPMI or DMEM with 10% FBS to detect bone‐metastatic cells from the primary tumor in the prostate. Data of all *in vivo* experiments were combined from two independent experiments. All procedures were done according to the protocol by approved Institutional Animal Care and Use Committee of National Health and Research Institutes, Taiwan (NHRI‐IACUC‐100130‐A; NHRI‐IACUC‐108015‐A).

Immunohistochemistry {#embr201845986-sec-0026}
--------------------

The paraffin‐embedded tissue sections of human PC specimens, including primary tumors, were obtained from commercial PC tissue array slides (US Biomax, Inc). The slides were sent to a pathology core lab (NHRI, Taiwan) for staining with CTH antibody (Abnova) by using an automatic slide stainer from BenchMark XT (Ventana Medical Systems, AZ).

Retrieving RNA‐seq data from The Cancer Genome Atlas {#embr201845986-sec-0027}
----------------------------------------------------

The normalized RNA‐seq data containing 469 prostate cancer (PC) cases, 50 normal cases, 174 pancreatic adenocarcinomas (PAAD), 528 lower grade glioma (LGG) cases, and patients' survival status were retrieved from The Cancer Genome Atlas (TCGA) (<https://cancergenome.nih.gov>). The clinical data of PC are summarized in [Appendix Table S2](#embr201845986-sup-0001){ref-type="supplementary-material"}. A total of 469 PC, 174 PAAD, and 528 LGG cases were included in the Kaplan--Meier survival analysis in this study.

Statistical analyses {#embr201845986-sec-0028}
--------------------

The statistical analyses were all assessed by GraphPad Prism using Student\'s *t*‐test to compare two means. ANOVA followed by Tukey\'s post hoc test was used for the statistical analysis when more than two means were compared (\**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001).
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